Beli & Jual Organon Pharma Indonesia Tbk. - SCPI – Harga Organon Pharma Indonesia Tbk. Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp4,12 T | +42.35% |
| Cost of Revenue | Rp3,68 T | +41.91% |
| Gross Profit | Rp439,66 M | +46.18% |
| General Expenses, Depreciation, Interest | Rp67,32 M | +1.71% |
| Operating Profit | Rp372,34 M | +58.73% |
| Other Income | Rp11,66 M | +64.26% |
| EBT | Rp383,99 M | +58.89% |
| Taxes | -Rp93,29 M | +69.45% |
| Net Income | Rp290,71 M | +55.78% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp2,28 T | +39.14% |
| Total Liabilities | Rp945,26 M | +56.77% |
| Total Equity | Rp1,33 T | +28.85% |
| Total Liabilities & Total Equity | Rp2,28 T | +39.14% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp196,79 M | +294.87% |
| CF from Investment | Rp13,8 M | -74.72% |
| CF from Financing | Rp2,88 M | +11.53% |
| Net Cash Flow | Rp180,11 M | -2563.88% |